Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

"I've said this before, but as more data comes in I become more convinced that we may look back on these drugs as the ...

A retrospective study found that women who took a GLP-1 drug for obesity were more likely to be diagnosed with acne vulgaris ...

Patients with type 2 diabetes who switched to tirzepatide rather than escalating their dulaglutide dosage had greater weight ...

The study finds better A1c lowering and weight reduction, but an expert clinician says practical issues may pose barriers.

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...

To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

It’s a little disheartening that so many of the questions (and comments) were focused on my body instead of my music, my ...